Library

The Oncology Business Dynamics training library is designed with oncology stakeholders in mind, from commercial and medical teams at pharma, to providers and administrators at practices.

Modulettes

We came up with the term “modulette” to describe our product evolution from long-form PDF modules into succinct, bite-sized modulettes that require less of a time investment. Our PDF modules covered a broad range of topics while our modultettes dive deep into a single topic, allowing us to provide a more enriching learning experience in a shorter period of time. Our library of 50+ modulettes is constantly updated, fully referenced, and can be accessed on your LMS or ours. Recently we’ve applied interactive capabilities to make our modulettes more engaging. To make our library more navigable, you will see below that we’ve broken the modulettes into themes/categories.

Value-Based Care Theme

  • Details the Enhancing Oncology Model, a CMS value-based payment program, which aims to shift federal oncology reimbursement away from fee-for-service care

  • Provides an overview of episode-based payment models piloted in oncology care

  • Provides a detailed view of the IRA, including how drug prices are negotiated and how the law impacts the delivery of cancer care

  • Details MACRA and the Quality Payment Program as part of the shift towards performance-adjusted payments and away from fee-for-service payments

  • Details key information on ACOs, helping providers understand the advantages and disadvantages of different ACO structures

  • Details the value-based Oncology Medical Home (OMH) payment model

  • Outlines the shift to value-based care, explores care frameworks and reimbursement strategies that consider patients' outcomes

  • Explains the various incentive-based payment programs that are moving providers and healthcare teams from fee-for-service to value-based healthcare

Foundational Theme

  • Outlines how evidence and consensus among experts is used to guide oncology care

  • Discusses the development and use of clinical guidelines to treat cancer patients

  • Defines the term “financial toxicity” and how it applies to patients with cancer

  • Explains the basics of a joining a GPO, the contracting process, and benefits for providers

  • Describes how implicit bias may affect interpersonal relationships in the healthcare setting among patients and coworkers

  • Explains the basics of MCOs and roles of key decision makers

  • An introduction to basic oncology concepts and terms ie disease setting, staging, and therapeutics while also explaining clinical development and commercialization

  • An overview of the cancer patient’s journey from the perspective of, and impact on, providers

  • An overview of strategies to understand, and cope with, grief as a result of death

  • Defines the various terms used in cancer drug pricing and physician-administered drug reimbursement

  • Provides basic knowledge on the two government-sponsored payment programs

Landscape Theme

  • Provides an overview of current cancer statistics including incidence rates, treatments, and disparities in care

  • Examines the impact of the cost of cancer care on individual patients and society at large

  • Explores the larger trends affecting oncology practices and how they treat cancer patients today

  • Provides an in-depth review of enrollment in, and drug reimbursement through, the federal 340B program

  • Explanation of how insurers use these strategies to shift the cost of drugs to manufacturers and patients

  • Explains the terms end-of-life care and advanced-care planning, as well as the differences between palliative care and hospice care

  • Follows an outpatient specialty drug used to treat cancer from manufacturer to treatment, and how its use impacts manufacturers, payers and patients along the way

  • Follows a physician-administered drug used in cancer through the pharmaceutical supply chain, including Medicare Part B's impact on reimbursement for patients and providers

  • Explains how data collected after the clinical trial process is used by payers and providers to guide decision-making

  • Provides key information on the formation of IDNs

  • Discusses the role of internal pharmacy dispensing and how it may reduce costs for providers

  • A deep dive into Medicare infrastructure, including an explanation of how Medicare reimbursement works across different settings

  • Details the process for reimbursing services covered under Medicare Part B

  • Explores the dynamics of Medicare Part D prescription drug programs

  • Expalins CMS-approved compendia and off-label use

  • Provides a look inside an oncology practice and how it functions, including how patients are administered care and how costs are managed

  • Provides an overview of costs and considerations for providers, patients, and payers when using specialty outpatient oral drugs in cancer care

  • Details tactics payers use to manage utilization of drugs and how payers use PBMs to contain costs and the impact this can have on patients

  • Exploration of the term “quality” in the delivery of cancer care, and how it helps identify value based, versus volume based, models of cancer care

  • Outlines the specialty drug marketplace and how SPPs help patients and providers access specialty drugs

  • Provides a high-level overview of VA and DoD policies and compares them with community care strategies

  • Defines the terms and what they mean in the distribution process of drugs used in cancer care

Business and Policy Theme

Innovations Theme

  • Details how novel technologies and research techniques are improving cancer care

  • Examines how big data and artificial intelligence is being harnessed to improve cancer care

  • Provides key information on the benefits of electronic health records, especially in relation to quality reporting and the shift to value-based care

  • Explains what a biosimilar drug is and the reimbursement policies that surround them

  • Provides and in-depth look into the burgeoning field of precision medicine in oncology, including the use of small molecules, monoclonal antibodies, and immune checkpoint inhibitors

Outliers

  • Explains each phase of the clinical process for a drug to attain FDA approval

  • Explains several emerging endpoints used in oncology clinical trials

  • Provides an explanation of statistical terms used in clinical trials

  • Takes the learner through the basics of KAM, such as prioritizing, value proposition, strategies, and metrics.

Learning Pathways

We created learning pathways to help navigate the OBD training library and help streamline your learning needs. Modulette titles are grouped into pathways that cover a broad range of topics. For example, the Payment Reform pathway includes titles related to the shift from volume to value.

  • The Federal Payer learning pathway covers many topics including, Medicare Part B Reimbursement, Medicare Part D Drug Plans, CMS Policies to Contain Costs, Medicare and Medicaid Administration, MACRA, an overview of Veterans Affairs (VA) and Department of Defense (DoD), as well as an intro course on What is Medicare and Medicaid.

    SEE PATHWAY MODULETTES

  • This Commercial Payer pathway covers various topics that begin with an Intro to Managed Care Organizations. Clinical Pathways, Clinical Guidelines, Specialty Pharmacy, White Bagging and Brown Bagging are covered as well as Payer and PBM Policies Used to Contain Costs, Follow the Vial and Follow the Pill.

    SEE PATHWAY MODULETTES

  • The Reimbursement pathway has everything you need to know about reimbursement including Medicare Part B drugs, difference between the medical benefit and pharmacy benefit, the evolution of reimbursement of physician-administered drugs, and the role of Medicare Administrators. Reimbursement terms, such ASP, AWP, MFP, and WAC are also defined and explained.

    SEE PATHWAY MODULETTES

  • Payment Reform is a sweeping topic and this pathway explains the many ways in which payment reform is shaping the delivery of cancer care from volume to value. Alternative payment models such as ACOs, oncology medical homes, episode-based payments, and the new Enhanced Oncology Model are included in this pathway.

    SEE PATHWAY MODULETTES

  • This pathway focuses on outpatient drugs covered under the pharmacy benefit and used in cancer care. Modulettes include Follow the Pill, Oral Oncology Drugs: An Overview, Specialty Pharmacy Providers, and Medically Integrated Dispensing in the practice setting.

    SEE PATHWAY MODULETTES

  • The Distribution learning pathway digs deep into the pharmaceutical supply chain. Modulettes cover topics that detail how drugs are distributed through the value chain from drug manufacturer to patient. Popular modulettes in this pathway include, Follow the Vial, Follow the Pill, Group Purchasing Organizations, White Bagging, Brown Bagging and Clear Bagging, and the Role of the Specialty Pharmacy Provider.

    SEE PATHWAY MODULETTES

  • This learning pathway identifies who the cancer patient is, current statistics on cancer, the impact of financial toxicity, and palliative care and end of life planning. Modulettes include Finanacial Toxicity and the Cancer Patient and Cancer Facts and Figures.

    SEE PATHWAY MODULETTES

  • Insights are provided into the rapidly changing dynamics of an oncology practice. Focus includes Oncology Practice Management, Current State of Oncology Care, Trends in Oncology Practice, Value-based Contracting, Integrated Delivery Networks, Health Information Technology, and others.

    SEE PATHWAY MODULETTES

  • This learning pathway discusses how emerging breakthroughs and innovative technologies in cancer research are transforming the delivery of cancer care. Immunotherapy Revolution, Molecular Diagnostics, Liquid Biopsies, Next Generation Sequencing, Big Data, Biosimilars, and Precision Medicine are all highlighted in our modulettes.

    SEE PATHWAY MODULETTES

  • If your new to the oncology space, this pathway includes modulettes that explain Clinical Trial Phases and Regulatory Approval, Explanation of Oncology Clinical Trial Enpoints, and Statistical Methods Used with Survival Endpoints. Clinical trial terms and endpoints can be complicated and we decipher all the terms you'll soon become familar with.

    SEE PATHWAY MODULETTES

  • We have a vast array of topics for new hires to get up to speed. From Clinical Pathways, Guidelines, to Office Practice Management, Follow the Pill, Follow the Vial, Reimbursement, Distribution, any of our modulettes would be appropriate to help new hires learn about topics to better engage with customers and coworkers with confidence.

    SEE PATHWAY MODULETTES

Our engagement with your teams begins here.
Contact us today.